DEFIBROTIDE SODIUM

DEFIBROTIDE SODIUM was reported 3584 times

DEFIBROTIDE SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEREDITARY RENAL MICROHAEMATURIA 1 1.0000
1 PARASITIC LUNG INFECTION 1 0.3333
2 VENOOCCLUSIVE DISEASE 565 0.2255
3 SPLENIC CANDIDIASIS 4 0.1739
4 GRANULICATELLA INFECTION 7 0.1667
5 SUBENDOCARDIAL HAEMORRHAGE 1 0.1250
6 COAGULATION TEST 1 0.1111
7 COLITIS HERPES 1 0.1000
8 ENCEPHALOMYELITIS VIRAL 1 0.0769
9 PULMONARY IMAGING PROCEDURE ABNORMAL 4 0.0714
10 VENOOCCLUSIVE LIVER DISEASE 347 0.0702
11 RED BLOOD CELL SCHISTOCYTES 1 0.0667
12 CONGENITAL DYSKERATOSIS 1 0.0526
13 CEREBRAL CIRCULATORY FAILURE 3 0.0484
14 VIRAL HAEMORRHAGIC CYSTITIS 32 0.0449
15 PNEUMONIA TOXOPLASMAL 1 0.0435
16 ACRAL PEELING SKIN SYNDROME 1 0.0435
17 TRANSPLANT ASSOCIATED THROMBOTIC MICROANGIOPATHY 1 0.0400
18 JUVENILE CHRONIC MYELOMONOCYTIC LEUKAEMIA 2 0.0392
19 ENGRAFT FAILURE 11 0.0383
20 IDIOPATHIC PNEUMONIA SYNDROME 11 0.0369
21 NEUROBLASTOMA RECURRENT 7 0.0345
22 DISSEMINATED INTRAVASCULAR COAGULATION IN NEWBORN 1 0.0323
23 ACUTE GRAFT VERSUS HOST DISEASE 140 0.0306
24 INCREASED LIVER STIFFNESS 1 0.0294
25 PORTAL VEIN PRESSURE INCREASED 1 0.0278
26 REFRACTORINESS TO PLATELET TRANSFUSION 3 0.0275
27 CITROBACTER SEPSIS 1 0.0250
28 PROPHYLAXIS 2 0.0244
29 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 50 0.0235
30 RHABDOMYOSARCOMA RECURRENT 1 0.0233
31 CYSTITIS HAEMORRHAGIC 93 0.0230
32 BLOOD BETA-D-GLUCAN INCREASED 7 0.0228
33 CYTOMEGALOVIRUS TEST 1 0.0222
34 GRAFT VERSUS HOST DISEASE IN LIVER 15 0.0209
35 URINARY TRACT CANDIDIASIS 4 0.0209
36 ENTEROBACTER TEST POSITIVE 5 0.0203
37 BACTERIAL PROSTATITIS 2 0.0202
38 SEPTIC CARDIOMYOPATHY 1 0.0200
39 TRACHEAL ULCER 1 0.0200
40 ADENOVIRAL HAEMORRHAGIC CYSTITIS 4 0.0192
41 CRYPTOCOCCUS TEST POSITIVE 1 0.0192
42 RHABDOID TUMOUR 1 0.0192
43 STAPHYLOCOCCUS TEST 1 0.0189
44 URINARY TRACT INFECTION VIRAL 2 0.0189
45 ACUTE MYELOID LEUKAEMIA RECURRENT 38 0.0177
46 HUMAN HERPESVIRUS 6 ENCEPHALITIS 5 0.0176
47 LARYNGEAL HAEMORRHAGE 2 0.0174
48 CHOLANGIOLITIS 1 0.0169
49 PERINEAL CELLULITIS 1 0.0169
50 CATHETER SITE SCAR 1 0.0167
51 SPINAL SUBARACHNOID HAEMORRHAGE 1 0.0167
52 HAEMORRHAGIC DISORDER 18 0.0165
53 STENOTROPHOMONAS SEPSIS 2 0.0165
54 BRONCHOALVEOLAR LAVAGE 1 0.0164
55 CUTANEOUS T-CELL LYMPHOMA RECURRENT 1 0.0159
56 CORYNEBACTERIUM SEPSIS 1 0.0152
57 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED RECURRENT 1 0.0149
58 EYELID HAEMATOMA 1 0.0147
59 INFERIOR VENA CAVA SYNDROME 1 0.0141
60 HAEMORRHAGIC ASCITES 4 0.0140
61 ENTEROCOCCUS TEST POSITIVE 9 0.0139
62 RESPIRATORY TRACT HAEMORRHAGE 8 0.0134
63 CHRONIC GRAFT VERSUS HOST DISEASE 48 0.0133
64 TRANSFUSION-RELATED ACUTE LUNG INJURY 4 0.0130
65 GRAFT VERSUS HOST DISEASE IN LUNG 6 0.0126
66 PRIMARY IMMUNODEFICIENCY SYNDROME 1 0.0123
67 SCLEREMA 1 0.0123
68 MULTIPLE ORGAN DYSFUNCTION SYNDROME 343 0.0121
69 TRANSPLANTATION COMPLICATION 5 0.0119
70 CORYNEBACTERIUM BACTERAEMIA 1 0.0118
71 SEPTIC ENCEPHALOPATHY 2 0.0116
72 INTESTINAL HAEMATOMA 2 0.0114
73 GRAFT VERSUS HOST DISEASE IN SKIN 25 0.0113
74 GRAFT VERSUS HOST DISEASE 80 0.0111
75 MUCOSA VESICLE 1 0.0111
76 COMPLICATIONS OF BONE MARROW TRANSPLANT 4 0.0111
77 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 28 0.0108
78 ACUTE BIPHENOTYPIC LEUKAEMIA 1 0.0108
79 CYSTITIS VIRAL 4 0.0104
80 AMYOTROPHY 4 0.0104
81 ACUTE LYMPHOCYTIC LEUKAEMIA 29 0.0102
82 GRAFT COMPLICATION 6 0.0102
83 GASTRITIS FUNGAL 1 0.0097
84 HAEMOBILIA 4 0.0096
85 POIKILODERMA 1 0.0093
86 KLEBSIELLA SEPSIS 10 0.0089
87 MEDULLOBLASTOMA RECURRENT 1 0.0088
88 ENTEROCOCCAL SEPSIS 7 0.0086
89 BK VIRUS INFECTION 29 0.0086
90 TRACHEAL HAEMORRHAGE 3 0.0085
91 ENGRAFTMENT SYNDROME 5 0.0085
92 NIEMANN-PICK DISEASE 1 0.0084
93 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 6 0.0083
94 HEPATORENAL SYNDROME 14 0.0083
95 CANDIDA ENDOPHTHALMITIS 1 0.0082
96 STOMATITIS HAEMORRHAGIC 1 0.0082
97 APLASIA 16 0.0082
98 PROTEIN-LOSING GASTROENTEROPATHY 4 0.0080
99 PNEUMONIA HERPES VIRAL 1 0.0079
100 BACTEROIDES INFECTION 2 0.0077
101 STENOTROPHOMONAS TEST POSITIVE 1 0.0075
102 ANTITHROMBIN III DECREASED 2 0.0073
103 PERICARDITIS INFECTIVE 1 0.0072
104 DUODENITIS HAEMORRHAGIC 1 0.0072
105 STARVATION 6 0.0072
106 PULMONARY ALVEOLAR HAEMORRHAGE 40 0.0071
107 PULMONARY INTERSTITIAL EMPHYSEMA SYNDROME 1 0.0070
108 BURKHOLDERIA CEPACIA COMPLEX INFECTION 2 0.0070
109 CENTRAL NERVOUS SYSTEM VIRAL INFECTION 1 0.0070
110 ADENOVIRUS INFECTION 20 0.0069
111 MUCOCUTANEOUS HAEMORRHAGE 1 0.0067
112 CANDIDA SEPSIS 6 0.0067
113 STENOTROPHOMONAS INFECTION 9 0.0066
114 ASPERGILLUS TEST POSITIVE 2 0.0065
115 CEREBRAL TOXOPLASMOSIS 6 0.0064
116 ENTEROBACTER PNEUMONIA 1 0.0064
117 ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA 2 0.0064
118 HEPATIC VEIN OCCLUSION 1 0.0063
119 SINUSITIS ASPERGILLUS 1 0.0063
120 ALLOGENIC STEM CELL TRANSPLANTATION 1 0.0063
121 FACTOR V DEFICIENCY 1 0.0063
122 COMBINED IMMUNODEFICIENCY 1 0.0062
123 PULMONARY HAEMORRHAGE 48 0.0061
124 HEPATIC CALCIFICATION 1 0.0061
125 CHRONIC MYELOMONOCYTIC LEUKAEMIA 4 0.0061
126 CYSTITIS KLEBSIELLA 1 0.0060
127 PNEUMONIA PARAINFLUENZAE VIRAL 1 0.0059
128 ACUTE MYELOID LEUKAEMIA REFRACTORY 1 0.0058
129 THROMBOTIC MICROANGIOPATHY 56 0.0057
130 MENINGOENCEPHALITIS VIRAL 1 0.0056
131 CYSTITIS ESCHERICHIA 2 0.0056
132 DIAPHRAGMATIC RUPTURE 1 0.0056
133 ACUTE MONOCYTIC LEUKAEMIA 1 0.0055
134 CUTANEOUS CALCIFICATION 1 0.0055
135 SPIDER NAEVUS 1 0.0054
136 ACINETOBACTER BACTERAEMIA 1 0.0053
137 HAEMOFILTRATION 1 0.0053
138 SYSTEMIC CANDIDA 13 0.0052
139 PSEUDOMONAL SEPSIS 9 0.0051
140 PNEUMONIA ADENOVIRAL 1 0.0051
141 DERMO-HYPODERMITIS 3 0.0050
142 ORAL BLOOD BLISTER 1 0.0050
143 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 4 0.0049
144 SODIUM RETENTION 1 0.0049
145 SPLENIC ARTERY ANEURYSM 1 0.0048
146 PRODUCT ADMINISTRATION ISSUE 1 0.0048
147 ENTEROBACTER INFECTION 8 0.0048
148 GEOTRICHUM INFECTION 1 0.0047
149 RETICULOCYTOSIS 1 0.0047
150 ABDOMINAL COMPARTMENT SYNDROME 3 0.0047
151 IMMOBILISATION SYNDROME 1 0.0047
152 SPINAL CORD HAEMATOMA 1 0.0047
153 CITROBACTER INFECTION 2 0.0047
154 GROWTH ACCELERATED 1 0.0046
155 BONE MARROW TRANSPLANT REJECTION 1 0.0045
156 MENINGOENCEPHALITIS HERPETIC 2 0.0045
157 HEPATIC RUPTURE 1 0.0045
158 SARCOMA 5 0.0044
159 GRAFT VERSUS HOST DISEASE IN EYE 1 0.0043
160 CENTRAL NERVOUS SYSTEM FUNGAL INFECTION 1 0.0043
161 MUCOSAL HAEMORRHAGE 5 0.0043
162 CENTRAL NERVOUS SYSTEM HAEMORRHAGE 2 0.0043
163 SYSTEMIC MYCOSIS 5 0.0043
164 URINARY OCCULT BLOOD POSITIVE 1 0.0043
165 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 6 0.0042
166 PUNCTURE SITE HAEMORRHAGE 3 0.0042
167 BRAIN STEM HAEMORRHAGE 4 0.0042
168 OVARIAN HAEMORRHAGE 1 0.0042
169 CARDIAC FAILURE HIGH OUTPUT 1 0.0041
170 CEREBROVASCULAR INSUFFICIENCY 1 0.0041
171 ILLNESS ANXIETY DISORDER 1 0.0041
172 RECTAL ULCER HAEMORRHAGE 1 0.0040
173 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 11 0.0040
174 CYTOMEGALOVIRUS GASTRITIS 1 0.0040
175 OESOPHAGEAL ULCER HAEMORRHAGE 2 0.0039
176 CYTOMEGALOVIRUS ENTEROCOLITIS 3 0.0039
177 COAGULATION TEST ABNORMAL 3 0.0039
178 TOXIC ERYTHEMA OF CHEMOTHERAPY 1 0.0039
179 INFECTIOUS COLITIS 2 0.0038
180 INTESTINAL SEPSIS 1 0.0038
181 MOUTH HAEMORRHAGE 28 0.0038
182 CRYPTOSPORIDIOSIS INFECTION 2 0.0038
183 PNEUMONIA KLEBSIELLA 7 0.0038
184 CORYNEBACTERIUM INFECTION 2 0.0037
185 ENTEROCOCCAL INFECTION 18 0.0037
186 B-CELL LYMPHOMA RECURRENT 2 0.0037
187 COAGULATION FACTOR DECREASED 1 0.0037
188 LIMBIC ENCEPHALITIS 1 0.0036
189 ACUTE MYELOID LEUKAEMIA 56 0.0036
190 SPLENIC HAEMATOMA 1 0.0035
191 MEDICAL DEVICE SITE HAEMORRHAGE 1 0.0035
192 ARTERIAL HAEMORRHAGE 4 0.0035
193 ACUTE RESPIRATORY DISTRESS SYNDROME 61 0.0034
194 HEPATITIS B SURFACE ANTIBODY POSITIVE 1 0.0034
195 PREMATURE AGEING 1 0.0034
196 FIBRIN DEGRADATION PRODUCTS INCREASED 1 0.0034
197 CARDIAC FUNCTION TEST ABNORMAL 1 0.0034
198 ASPERGILLUS INFECTION 22 0.0033
199 ESCHERICHIA TEST POSITIVE 4 0.0033
200 DUODENAL OBSTRUCTION 1 0.0033
201 ENTEROCOLITIS VIRAL 1 0.0033
202 CEREBRAL ASPERGILLOSIS 2 0.0033
203 URAEMIC ENCEPHALOPATHY 1 0.0032
204 EPSTEIN-BARR VIRUS TEST POSITIVE 2 0.0032
205 BLADDER INJURY 1 0.0031
206 CANDIDA PNEUMONIA 1 0.0031
207 BRONCHOPULMONARY ASPERGILLOSIS 24 0.0031
208 COAGULATION FACTOR V LEVEL DECREASED 1 0.0031
209 DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV 1 0.0030
210 BRONCHITIS VIRAL 2 0.0030
211 LEUKAEMIA RECURRENT 5 0.0030
212 CYTOMEGALOVIRUS INFECTION REACTIVATION 13 0.0029
213 ANASTOMOTIC COMPLICATION 1 0.0029
214 EMBOLISM 24 0.0029
215 PULMONARY VENO-OCCLUSIVE DISEASE 2 0.0029
216 TRANSPLANT FAILURE 7 0.0029
217 IDIOPATHIC INTERSTITIAL PNEUMONIA 1 0.0028
218 KLEBSIELLA INFECTION 14 0.0028
219 CEREBRAL MASS EFFECT 1 0.0028
220 ANGIODYSPLASIA 1 0.0027
221 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 1 0.0027
222 ENTEROBACTER SEPSIS 1 0.0027
223 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 20 0.0027
224 HUMAN HERPESVIRUS 6 INFECTION 5 0.0026
225 NEUROBLASTOMA 1 0.0026
226 B PRECURSOR TYPE ACUTE LEUKAEMIA 1 0.0026
227 SHOCK HAEMORRHAGIC 21 0.0026
228 LOWER RESPIRATORY TRACT INFECTION FUNGAL 1 0.0026
229 LOWER GASTROINTESTINAL HAEMORRHAGE 19 0.0026
230 CENTRAL NERVOUS SYSTEM LEUKAEMIA 1 0.0025
231 FUNGAEMIA 4 0.0025
232 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 24 0.0025
233 HAEMOPERITONEUM 2 0.0025
234 SPINAL CORD HAEMORRHAGE 1 0.0025
235 PARVOVIRUS INFECTION 1 0.0025
236 URETHRAL OBSTRUCTION 1 0.0025
237 BACTERIAL SEPSIS 8 0.0025
238 PERIORBITAL HAEMATOMA 2 0.0024
239 PULMONARY CALCIFICATION 1 0.0024
240 SEPTIC EMBOLUS 2 0.0024
241 SEPTIC SHOCK 104 0.0024
242 URINARY TRACT INFECTION BACTERIAL 6 0.0024
243 HYPERFERRITINAEMIA 1 0.0023
244 MELAENA 51 0.0023
245 MANTLE CELL LYMPHOMA RECURRENT 1 0.0023
246 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 3 0.0023
247 ABDOMINAL SEPSIS 2 0.0023
248 BLADDER HYPERTROPHY 1 0.0023
249 INTENTIONAL PRODUCT USE ISSUE 198 0.0023
250 HYPERLEUKOCYTOSIS 2 0.0023
251 CYTOMEGALOVIRUS TEST POSITIVE 4 0.0022
252 NEUROLOGICAL DECOMPENSATION 5 0.0022
253 URINARY TRACT INFECTION ENTEROCOCCAL 2 0.0021
254 ACUTE PULMONARY OEDEMA 12 0.0021
255 MICROANGIOPATHY 2 0.0021
256 PULMONARY TOXICITY 15 0.0021
257 FEBRILE BONE MARROW APLASIA 9 0.0021
258 INTRACRANIAL MASS 2 0.0021
259 HEPATIC HAEMATOMA 1 0.0021
260 EPSTEIN-BARR VIRUS INFECTION 13 0.0021
261 ESCHERICHIA SEPSIS 6 0.0021
262 PNEUMONIA HAEMOPHILUS 1 0.0021
263 ARTERIOVENOUS FISTULA 1 0.0020
264 MUCOSAL DISORDER 2 0.0020
265 CATHETER SITE HAEMORRHAGE 5 0.0020
266 SMALL INTESTINAL HAEMORRHAGE 4 0.0020
267 CYTOMEGALOVIRUS INFECTION 33 0.0020
268 VARICES OESOPHAGEAL 6 0.0020
269 URINARY TRACT PAIN 1 0.0020
270 HAEMORRHAGIC DIATHESIS 7 0.0020
271 RENAL HAEMATOMA 1 0.0019
272 OCCULT BLOOD 1 0.0019
273 URINARY BLADDER HAEMORRHAGE 4 0.0019
274 HAEMATURIA 65 0.0019
275 RESPIRATORY TRACT INFECTION FUNGAL 1 0.0019
276 GASTRIC ANTRAL VASCULAR ECTASIA 1 0.0019
277 HYPERLACTACIDAEMIA 5 0.0019
278 ORCHITIS 2 0.0019
279 GALLBLADDER ENLARGEMENT 2 0.0019
280 TOXOPLASMOSIS 2 0.0019
281 BLEEDING VARICOSE VEIN 1 0.0018
282 RENAL ISCHAEMIA 1 0.0018
283 STAPHYLOCOCCAL SEPSIS 9 0.0018
284 SEROSITIS 1 0.0018
285 HYPERNATRAEMIA 9 0.0018
286 EPSTEIN-BARR VIRAEMIA 2 0.0018
287 INTRACRANIAL HAEMATOMA 1 0.0018
288 PORTAL HYPERTENSIVE GASTROPATHY 1 0.0018
289 BACTERIURIA 1 0.0018
290 ROTAVIRUS INFECTION 1 0.0017
291 ORGAN FAILURE 7 0.0017
292 MEDIASTINITIS 1 0.0017
293 PAROTITIS 2 0.0017
294 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 1 0.0017
295 HAEMORRHAGE SUBCUTANEOUS 6 0.0017
296 BACTERAEMIA 20 0.0017
297 ACIDOSIS HYPERCHLORAEMIC 1 0.0017
298 PNEUMONIA INFLUENZAL 2 0.0017
299 INTRA-ABDOMINAL HAEMORRHAGE 4 0.0017
300 MYELODYSPLASTIC SYNDROME 24 0.0017
301 URETHRAL HAEMORRHAGE 1 0.0017
302 MYELOFIBROSIS 5 0.0017
303 CLOSTRIDIUM COLITIS 2 0.0016
304 BLOOD BILIRUBIN INCREASED 44 0.0016
305 PHARYNGEAL HAEMORRHAGE 2 0.0016
306 BLOOD BILIRUBIN DECREASED 1 0.0016
307 STAPHYLOCOCCAL BACTERAEMIA 7 0.0016
308 BACILLUS INFECTION 1 0.0016
309 RETINAL ARTERY OCCLUSION 4 0.0016
310 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 8 0.0016
311 UPPER GASTROINTESTINAL HAEMORRHAGE 26 0.0015
312 C-REACTIVE PROTEIN DECREASED 1 0.0015
313 GASTROINTESTINAL MUCOSAL DISORDER 1 0.0015
314 MYELOPROLIFERATIVE NEOPLASM 1 0.0015
315 HAEMORRHAGE 157 0.0015
316 GASTROINTESTINAL HAEMORRHAGE 123 0.0015
317 MARROW HYPERPLASIA 1 0.0015
318 CAPILLARY LEAK SYNDROME 3 0.0014
319 FUSARIUM INFECTION 1 0.0014
320 OFF LABEL USE 1245 0.0014
321 PELVIC FLUID COLLECTION 1 0.0014
322 MENINGITIS BACTERIAL 2 0.0014
323 HEPATIC ENCEPHALOPATHY 13 0.0014
324 OESOPHAGEAL VARICES HAEMORRHAGE 3 0.0014
325 GASTRIC MUCOSAL LESION 1 0.0014
326 SUBARACHNOID HAEMORRHAGE 14 0.0014
327 B-CELL TYPE ACUTE LEUKAEMIA 1 0.0014
328 HEPATITIS FULMINANT 4 0.0013
329 GASTRITIS HAEMORRHAGIC 2 0.0013
330 SUBDURAL HAEMATOMA 19 0.0013
331 HEPATIC FAILURE 40 0.0013
332 PARAINFLUENZAE VIRUS INFECTION 2 0.0013
333 OBSTRUCTIVE PANCREATITIS 1 0.0013
334 CYTOMEGALOVIRUS COLITIS 3 0.0013
335 PNEUMONIA PSEUDOMONAL 2 0.0013
336 LYMPHOMA 20 0.0013
337 PULMONARY MYCOSIS 1 0.0013
338 PSEUDOMONAS INFECTION 11 0.0013
339 INTERSTITIAL LUNG DISEASE 62 0.0013
340 PNEUMONIA FUNGAL 5 0.0013
341 CARDIAC TAMPONADE 6 0.0013
342 ASCITES 37 0.0013
343 PURPURA 11 0.0012
344 INCISION SITE HAEMORRHAGE 1 0.0012
345 CARDIOTOXICITY 11 0.0012
346 CEREBRAL HAEMORRHAGE 44 0.0012
347 PSEUDOMONAS TEST POSITIVE 1 0.0012
348 GLOMERULAR FILTRATION RATE INCREASED 1 0.0012
349 VENA CAVA THROMBOSIS 2 0.0012
350 STEM CELL TRANSPLANT 3 0.0012
351 SUPERFICIAL VEIN THROMBOSIS 1 0.0012
352 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 1 0.0012
353 HEPATITIS A 1 0.0012
354 ENZYME LEVEL INCREASED 1 0.0012
355 ALTERED STATE OF CONSCIOUSNESS 25 0.0012
356 INCORRECT PRODUCT ADMINISTRATION DURATION 25 0.0012
357 THALAMUS HAEMORRHAGE 1 0.0011
358 PETECHIAE 12 0.0011
359 CLOSTRIDIUM DIFFICILE COLITIS 12 0.0011
360 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 2 0.0011
361 GASTRIC HAEMORRHAGE 13 0.0011
362 DRUG LEVEL FLUCTUATING 1 0.0011
363 HEPATOMEGALY 11 0.0011
364 INTRA-ABDOMINAL FLUID COLLECTION 2 0.0011
365 ESCHERICHIA INFECTION 9 0.0011
366 ANEURYSM RUPTURED 1 0.0011
367 SEPSIS 121 0.0011
368 HAEMOCHROMATOSIS 1 0.0011
369 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0011
370 PROTHROMBIN LEVEL DECREASED 1 0.0011
371 CHOLECYSTITIS ACUTE 6 0.0011
372 KLEBSIELLA BACTERAEMIA 1 0.0011
373 ENTEROCOLITIS 6 0.0010
374 HEPATIC MASS 2 0.0010
375 ONCOLOGIC COMPLICATION 1 0.0010
376 HAEMOTHORAX 3 0.0010
377 BLADDER CATHETERISATION 1 0.0010
378 COAGULOPATHY 17 0.0010
379 DUODENAL PERFORATION 1 0.0010
380 DEVICE RELATED THROMBOSIS 1 0.0010
381 PNEUMONIA STAPHYLOCOCCAL 2 0.0010
382 PYURIA 1 0.0010
383 HISTIOCYTOSIS HAEMATOPHAGIC 3 0.0010
384 CELL DEATH 2 0.0010
385 METABOLIC ENCEPHALOPATHY 3 0.0010
386 DEVICE RELATED SEPSIS 2 0.0010
387 EAR HAEMORRHAGE 2 0.0010
388 NEPHROPATHY TOXIC 11 0.0010
389 SPONTANEOUS HAEMORRHAGE 1 0.0010
390 NEUTROPENIC COLITIS 2 0.0010
391 ABSCESS JAW 1 0.0010
392 CONSCIOUSNESS FLUCTUATING 1 0.0010
393 ATRIAL TACHYCARDIA 2 0.0010
394 IRON OVERLOAD 1 0.0009
395 PRODUCT NAME CONFUSION 1 0.0009
396 ACARODERMATITIS 1 0.0009
397 ACINETOBACTER INFECTION 1 0.0009
398 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 2 0.0009
399 RESPIRATORY DISTRESS 25 0.0009
400 CARDIAC HYPERTROPHY 1 0.0009
401 HAEMOGLOBINURIA 1 0.0009
402 GASTROINTESTINAL ULCER HAEMORRHAGE 1 0.0009
403 CANDIDA INFECTION 15 0.0009
404 BLOOD FIBRINOGEN DECREASED 1 0.0009
405 DIFFUSE ALVEOLAR DAMAGE 1 0.0009
406 HAEMANGIOMA 2 0.0009
407 RESPIRATORY FAILURE 63 0.0009
408 HAEMOLYTIC URAEMIC SYNDROME 2 0.0009
409 EPIDIDYMITIS 1 0.0009
410 EPISTAXIS 64 0.0009
411 DISSEMINATED INTRAVASCULAR COAGULATION 12 0.0009
412 ESCHERICHIA BACTERAEMIA 2 0.0008
413 DISEASE PROGRESSION 99 0.0008
414 MULTIMORBIDITY 1 0.0008
415 HAEMATOMA MUSCLE 1 0.0008
416 DIABETES INSIPIDUS 2 0.0008
417 CHRONIC RESPIRATORY FAILURE 1 0.0008
418 HAEMATEMESIS 21 0.0008
419 LIVER TRANSPLANT 3 0.0008
420 PERICARDIAL EFFUSION 19 0.0008
421 HAEMATOLOGICAL INFECTION 2 0.0008
422 LARGE INTESTINE INFECTION 1 0.0008
423 WOUND HAEMORRHAGE 3 0.0008
424 INTRA-ABDOMINAL HAEMATOMA 1 0.0008
425 ORGANISING PNEUMONIA 4 0.0008
426 HYPOTENSION 160 0.0008
427 PLATELET DISORDER 2 0.0008
428 GASTRIC ULCER PERFORATION 1 0.0008
429 HYPERTHERMIA 6 0.0008
430 SUBCUTANEOUS HAEMATOMA 1 0.0008
431 RENAL FAILURE 104 0.0008
432 HEPATOSPLENOMEGALY 2 0.0008
433 PLATELET TRANSFUSION 1 0.0008
434 COUNTERFEIT PRODUCT ADMINISTERED 1 0.0008
435 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 2 0.0008
436 LUNG OPACITY 2 0.0008
437 STAPHYLOCOCCAL INFECTION 25 0.0008
438 OESOPHAGEAL HAEMORRHAGE 1 0.0008
439 OESOPHAGITIS 8 0.0007
440 IMMUNOGLOBULINS DECREASED 1 0.0007
441 VITREOUS HAEMORRHAGE 2 0.0007
442 ENCEPHALITIS 5 0.0007
443 PERITONEAL HAEMORRHAGE 1 0.0007
444 PROTHROMBIN TIME SHORTENED 1 0.0007
445 ALVEOLITIS 1 0.0007
446 TONIC CONVULSION 1 0.0007
447 INTENSIVE CARE 1 0.0007
448 TUMOUR HAEMORRHAGE 2 0.0007
449 TRACHEOSTOMY 1 0.0007
450 CEREBELLAR HAEMORRHAGE 1 0.0007
451 DUODENAL ULCER HAEMORRHAGE 2 0.0007
452 FEBRILE NEUTROPENIA 46 0.0007
453 OCULAR ICTERUS 3 0.0007
454 POST PROCEDURAL HAEMORRHAGE 8 0.0007
455 GASTROINTESTINAL NECROSIS 2 0.0007
456 HAEMOPTYSIS 19 0.0007
457 SKIN STRIAE 1 0.0007
458 PROTHROMBIN TIME PROLONGED 4 0.0007
459 BLOOD CULTURE POSITIVE 2 0.0007
460 CRANIOCEREBRAL INJURY 2 0.0007
461 INFECTIOUS PLEURAL EFFUSION 1 0.0007
462 DYSAESTHESIA 2 0.0007
463 ENCEPHALOPATHY 16 0.0007
464 CALCULUS URINARY 1 0.0006
465 MYELITIS 1 0.0006
466 GASTROSTOMY 1 0.0006
467 BLOOD BLISTER 2 0.0006
468 HEPATOCELLULAR INJURY 9 0.0006
469 BILE DUCT STONE 2 0.0006
470 JC VIRUS INFECTION 1 0.0006
471 PNEUMONIA LEGIONELLA 1 0.0006
472 PORTAL VEIN THROMBOSIS 2 0.0006
473 MUCOSAL INFLAMMATION 16 0.0006
474 HYPERVOLAEMIA 3 0.0006
475 HAEMORRHAGE INTRACRANIAL 9 0.0006
476 MENINGITIS 4 0.0006
477 SALMONELLOSIS 1 0.0006
478 SPLEEN DISORDER 1 0.0006
479 THROMBOCYTOPENIA 66 0.0006
480 LOWER RESPIRATORY TRACT CONGESTION 1 0.0006
481 ENTERITIS INFECTIOUS 1 0.0006
482 AUTOIMMUNE HAEMOLYTIC ANAEMIA 2 0.0006
483 ECCHYMOSIS 4 0.0006
484 URINE OUTPUT DECREASED 5 0.0006
485 TUMOUR LYSIS SYNDROME 5 0.0006
486 IMMUNOSUPPRESSION 5 0.0006
487 JUGULAR VEIN THROMBOSIS 1 0.0006
488 RETINAL HAEMORRHAGE 4 0.0006
489 PNEUMOMEDIASTINUM 1 0.0006
490 DERMATITIS BULLOUS 4 0.0006
491 MAJOR DEPRESSION 4 0.0005
492 GASTRIC ULCER HAEMORRHAGE 3 0.0005
493 BONE MARROW FAILURE 11 0.0005
494 DEATH 465 0.0005
495 CARDIAC DYSFUNCTION 2 0.0005
496 LEUKOENCEPHALOPATHY 2 0.0005
497 NASAL OBSTRUCTION 1 0.0005
498 SMALL INTESTINAL PERFORATION 1 0.0005
499 BLOOD IRON INCREASED 1 0.0005
500 BONE MARROW TRANSPLANT 1 0.0005
501 HAEMODYNAMIC INSTABILITY 4 0.0005
502 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
503 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 2 0.0005
504 HERPES VIRUS INFECTION 3 0.0005
505 ACUTE RESPIRATORY FAILURE 10 0.0005
506 RHINOVIRUS INFECTION 2 0.0005
507 INFECTION 74 0.0005
508 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 28 0.0005
509 BICYTOPENIA 1 0.0005
510 MULTI-ORGAN DISORDER 1 0.0005
511 ANAPHYLACTIC SHOCK 13 0.0005
512 CLOSTRIDIUM DIFFICILE INFECTION 11 0.0005
513 AZOTAEMIA 2 0.0005
514 MUSCLE HAEMORRHAGE 2 0.0005
515 RENAL HAEMORRHAGE 1 0.0005
516 OLIGURIA 3 0.0005
517 PLEURAL EFFUSION 29 0.0005
518 DEVICE CONNECTION ISSUE 1 0.0005
519 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
520 CIRCULATORY COLLAPSE 8 0.0005
521 CHOLESTASIS 9 0.0005
522 HYPERPHOSPHATAEMIA 1 0.0005
523 PYELONEPHRITIS 4 0.0005
524 HEPATITIS ACUTE 3 0.0005
525 CORONAVIRUS INFECTION 3 0.0005
526 TONGUE BLISTERING 1 0.0004
527 LARGE INTESTINAL OBSTRUCTION 1 0.0004
528 GASTRIC POLYPS 1 0.0004
529 VASCULAR DEVICE INFECTION 2 0.0004
530 LICHENOID KERATOSIS 1 0.0004
531 PNEUMONIA BACTERIAL 4 0.0004
532 LUNG DISORDER 21 0.0004
533 BILIRUBIN CONJUGATED INCREASED 1 0.0004
534 PULMONARY OEDEMA 19 0.0004
535 DRUG LEVEL INCREASED 7 0.0004
536 TRANSPLANT 1 0.0004
537 FUNGAL INFECTION 14 0.0004
538 HAEMATOCHEZIA 23 0.0004
539 GASTROINTESTINAL OBSTRUCTION 1 0.0004
540 HAEMORRHOIDAL HAEMORRHAGE 2 0.0004
541 RETROPERITONEAL HAEMORRHAGE 1 0.0004
542 INTRAVENTRICULAR HAEMORRHAGE 1 0.0004
543 HYPERAMMONAEMIA 2 0.0004
544 OSTEITIS 1 0.0004
545 METASTASES TO PERITONEUM 1 0.0004
546 RECTAL HAEMORRHAGE 17 0.0004
547 TOXIC ENCEPHALOPATHY 2 0.0004
548 HAEMORRHAGE URINARY TRACT 1 0.0004
549 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 2 0.0004
550 ACIDOSIS 3 0.0004
551 PRODUCT TEMPERATURE EXCURSION ISSUE 2 0.0004
552 CACHEXIA 2 0.0004
553 HYPERBILIRUBINAEMIA 4 0.0004
554 HYPOALBUMINAEMIA 3 0.0004
555 MUCORMYCOSIS 1 0.0004
556 AREFLEXIA 1 0.0004
557 ABDOMINAL MASS 1 0.0004
558 GASTROINTESTINAL INJURY 1 0.0004
559 BLOOD SODIUM INCREASED 1 0.0004
560 FAECES DISCOLOURED 8 0.0004
561 TACHYPNOEA 5 0.0004
562 INTESTINAL ISCHAEMIA 2 0.0004
563 RASH MORBILLIFORM 1 0.0004
564 MALNUTRITION 4 0.0004
565 ENDOTRACHEAL INTUBATION 1 0.0004
566 PSYCHOMOTOR RETARDATION 1 0.0004
567 STATUS EPILEPTICUS 4 0.0004
568 NEUTROPHIL COUNT ABNORMAL 1 0.0004
569 CARDIOGENIC SHOCK 5 0.0003
570 HYPOGLYCAEMIC COMA 1 0.0003
571 PARAPLEGIA 1 0.0003
572 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
573 LYMPHOPROLIFERATIVE DISORDER 1 0.0003
574 STRIDOR 1 0.0003
575 PERITONITIS 7 0.0003
576 TACHYCARDIA 30 0.0003
577 IMMUNODEFICIENCY 5 0.0003
578 BRAIN HERNIATION 1 0.0003
579 GASTROINTESTINAL INFECTION 3 0.0003
580 ATYPICAL PNEUMONIA 1 0.0003
581 CEREBROVASCULAR DISORDER 1 0.0003
582 PORTAL HYPERTENSION 1 0.0003
583 BRAIN DEATH 1 0.0003
584 MULTIPLE-DRUG RESISTANCE 1 0.0003
585 LUNG INFECTION 5 0.0003
586 DIARRHOEA HAEMORRHAGIC 3 0.0003
587 INCORRECT DRUG ADMINISTRATION DURATION 9 0.0003
588 LEUKAEMIA 3 0.0003
589 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
590 UNDERDOSE 23 0.0003
591 BLADDER PAIN 1 0.0003
592 ORTHOPNOEA 1 0.0003
593 HEPATIC CYTOLYSIS 4 0.0003
594 PNEUMONIA VIRAL 1 0.0003
595 PANCREATITIS ACUTE 7 0.0003
596 DRUG RESISTANCE 8 0.0003
597 CARDIO-RESPIRATORY ARREST 13 0.0003
598 ATELECTASIS 3 0.0003
599 HAEMATOMA 8 0.0003
600 PLASMA CELL MYELOMA RECURRENT 1 0.0003
601 OTITIS MEDIA 1 0.0003
602 CEREBRAL HAEMATOMA 1 0.0003
603 DISEASE RECURRENCE 14 0.0003
604 HEPATIC FIBROSIS 1 0.0003
605 APLASIA PURE RED CELL 1 0.0003
606 HAIR GROWTH ABNORMAL 2 0.0003
607 RENAL IMPAIRMENT 24 0.0003
608 THROMBOPHLEBITIS 1 0.0003
609 BRONCHIOLITIS 1 0.0003
610 THROMBOTIC THROMBOCYTOPENIC PURPURA 1 0.0003
611 JAUNDICE CHOLESTATIC 1 0.0003
612 GLOSSITIS 1 0.0003
613 FLUID OVERLOAD 4 0.0003
614 ACUTE KIDNEY INJURY 42 0.0003
615 BLOOD PHOSPHORUS DECREASED 1 0.0003
616 ORAL DISORDER 2 0.0003
617 SKIN HAEMORRHAGE 4 0.0003
618 RESPIRATORY DISORDER 8 0.0003
619 HEPATIC NECROSIS 1 0.0003
620 PLATELET COUNT DECREASED 28 0.0003
621 INTERNAL HAEMORRHAGE 3 0.0003
622 TONGUE OEDEMA 1 0.0003
623 MYOCARDITIS 3 0.0003
624 PULMONARY FIBROSIS 5 0.0003
625 DIFFUSE LARGE B-CELL LYMPHOMA 2 0.0003
626 HAEMOLYSIS 2 0.0003
627 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
628 OESOPHAGEAL CANDIDIASIS 1 0.0003
629 PANCYTOPENIA 14 0.0003
630 OBSTRUCTION 1 0.0003
631 LIVER DISORDER 11 0.0002
632 PNEUMONIA 80 0.0002
633 DECUBITUS ULCER 2 0.0002
634 RECURRENT CANCER 1 0.0002
635 CYTOPENIA 3 0.0002
636 ARTHRITIS BACTERIAL 1 0.0002
637 HYPERAESTHESIA 2 0.0002
638 CONDITION AGGRAVATED 74 0.0002
639 EXTRAVASATION 1 0.0002
640 GENERALISED OEDEMA 3 0.0002
641 BRAIN OEDEMA 3 0.0002
642 MUSCLE ATROPHY 3 0.0002
643 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
644 METRORRHAGIA 4 0.0002
645 HEPATIC PAIN 1 0.0002
646 GENITAL HAEMORRHAGE 3 0.0002
647 CARDIAC MURMUR 2 0.0002
648 LUNG INFILTRATION 2 0.0002
649 NERVOUS SYSTEM DISORDER 7 0.0002
650 ILEUS PARALYTIC 1 0.0002
651 OEDEMA 12 0.0002
652 ACUTE HEPATIC FAILURE 3 0.0002
653 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
654 DISEASE COMPLICATION 1 0.0002
655 CHRONIC MYELOID LEUKAEMIA 1 0.0002
656 LOCALISED OEDEMA 1 0.0002
657 HEPATIC FUNCTION ABNORMAL 8 0.0002
658 NEPHROPATHY 2 0.0002
659 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
660 HYPOVOLAEMIC SHOCK 1 0.0002
661 GUILLAIN-BARRE SYNDROME 1 0.0002
662 PRESCRIBED OVERDOSE 4 0.0002
663 INCORRECT DOSAGE ADMINISTERED 1 0.0002
664 CARDIOMYOPATHY 3 0.0002
665 ABDOMINAL TENDERNESS 1 0.0002
666 PNEUMOCYSTIS JIROVECII PNEUMONIA 2 0.0002
667 PRODUCT ADMINISTRATION ERROR 4 0.0002
668 ENDOCARDITIS 1 0.0002
669 HYPERGLYCAEMIA 7 0.0002
670 APLASTIC ANAEMIA 1 0.0002
671 WEIGHT FLUCTUATION 2 0.0002
672 SERUM FERRITIN INCREASED 1 0.0002
673 CARDIAC FAILURE 15 0.0002
674 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
675 PNEUMONITIS 5 0.0002
676 HYDROCEPHALUS 1 0.0002
677 STREPTOCOCCAL INFECTION 1 0.0002
678 HEPATOTOXICITY 4 0.0002
679 BLOOD UREA INCREASED 3 0.0002
680 INTERMENSTRUAL BLEEDING 1 0.0002
681 PERICARDITIS 3 0.0002
682 ANGIOPATHY 1 0.0002
683 SHOCK 4 0.0002
684 DELIRIUM 6 0.0002
685 RENAL DISORDER 8 0.0002
686 PRODUCT LABEL CONFUSION 1 0.0002
687 HYPOVOLAEMIA 1 0.0002
688 SPLENOMEGALY 2 0.0002
689 COVID-19 PNEUMONIA 2 0.0002
690 CHOLECYSTITIS 2 0.0002
691 HYPERCALCAEMIA 2 0.0002
692 PIGMENTATION DISORDER 1 0.0002
693 PRE-EXISTING CONDITION IMPROVED 1 0.0002
694 COLITIS 6 0.0002
695 HEPATITIS 4 0.0002
696 ENTERITIS 1 0.0002
697 PROCTALGIA 1 0.0002
698 HERPES SIMPLEX 1 0.0002
699 ANGINA UNSTABLE 1 0.0002
700 PRODUCT PREPARATION ISSUE 1 0.0002
701 HYPOGAMMAGLOBULINAEMIA 1 0.0002
702 CARDIAC FAILURE ACUTE 1 0.0001
703 BRONCHIECTASIS 1 0.0001
704 ULCER HAEMORRHAGE 1 0.0001
705 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
706 GINGIVAL BLEEDING 2 0.0001
707 PERIPHERAL COLDNESS 2 0.0001
708 RESPIRATION ABNORMAL 1 0.0001
709 HYPOMAGNESAEMIA 2 0.0001
710 DUODENAL ULCER 1 0.0001
711 DIALYSIS 2 0.0001
712 BRONCHOSPASM 2 0.0001
713 METASTASIS 1 0.0001
714 NEUTROPENIC SEPSIS 1 0.0001
715 BLOOD CREATININE INCREASED 9 0.0001
716 INTENTIONAL UNDERDOSE 1 0.0001
717 HYPOPHOSPHATAEMIA 1 0.0001
718 TRANSAMINASES INCREASED 3 0.0001
719 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
720 DEVICE RELATED INFECTION 2 0.0001
721 FOOD ALLERGY 1 0.0001
722 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 9 0.0001
723 COMA 6 0.0001
724 METABOLIC ACIDOSIS 4 0.0001
725 PRODUCT USE IN UNAPPROVED INDICATION 31 0.0001
726 TRANSPLANT REJECTION 1 0.0001
727 OXYGEN SATURATION DECREASED 7 0.0001
728 SENSORY LOSS 1 0.0001
729 RHINITIS 1 0.0001
730 FRUSTRATION TOLERANCE DECREASED 1 0.0001
731 NEURALGIA 3 0.0001
732 CEREBRAL INFARCTION 3 0.0001
733 ASPHYXIA 1 0.0001
734 HERPES ZOSTER 7 0.0001
735 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 1 0.0001
736 GENERAL PHYSICAL HEALTH DETERIORATION 14 0.0001
737 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
738 ABDOMINAL PAIN 28 0.0001
739 FACIAL PARALYSIS 1 0.0001
740 NEOPLASM PROGRESSION 4 0.0001
741 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
742 GASTRITIS 3 0.0001
743 JAUNDICE 3 0.0001
744 LEUKOCYTOSIS 2 0.0001
745 PATHOGEN RESISTANCE 1 0.0001
746 CARDIAC ARREST 9 0.0001
747 BRAIN NEOPLASM 1 0.0001
748 HEPATIC STEATOSIS 2 0.0001
749 GASTRIC ULCER 2 0.0001
750 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
751 SINUS BRADYCARDIA 1 0.0001
752 AUTOIMMUNE DISORDER 1 0.0001
753 INABILITY TO AFFORD MEDICATION 1 0.0001
754 NO ADVERSE EVENT 18 0.0001
755 TOXIC SKIN ERUPTION 1 0.0001
756 HYPOTHERMIA 1 0.0001
757 TOOTH ABSCESS 1 0.0001
758 PRODUCT PREPARATION ERROR 2 0.0001
759 INFLAMMATION 5 0.0001
760 PULMONARY HYPERTENSION 2 0.0001
761 DERMATITIS 2 0.0001
762 FULL BLOOD COUNT ABNORMAL 1 0.0001
763 BRADYCARDIA 5 0.0001
764 ASPARTATE AMINOTRANSFERASE INCREASED 5 0.0001
765 ATRIAL FIBRILLATION 9 0.0001
766 IMPAIRED HEALING 3 0.0001
767 DENTAL CARIES 1 0.0001
768 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
769 SKIN DISORDER 3 0.0001
770 RASH MACULO-PAPULAR 2 0.0001
771 HYPERTENSIVE CRISIS 1 0.0001
772 PYREXIA 31 0.0001
773 NEOPLASM 1 0.0001
774 HYPOKALAEMIA 4 0.0001
775 METASTASES TO LUNG 1 0.0001
776 ELECTROLYTE IMBALANCE 1 0.0001
777 EYELID OEDEMA 1 0.0001
778 HYPOXIA 3 0.0001
779 DRUG INTOLERANCE 8 0.0001
780 PRESYNCOPE 2 0.0001
781 RESTLESSNESS 3 0.0001
782 LIVER INJURY 2 0.0001
783 ALANINE AMINOTRANSFERASE INCREASED 5 0.0001
784 CARDIOMEGALY 1 0.0001
785 SMALL INTESTINAL OBSTRUCTION 1 0.0001
786 ILEUS 1 0.0001
787 HAIR COLOUR CHANGES 1 0.0001
788 PNEUMONIA ASPIRATION 2 0.0001
789 LEUKOPENIA 4 0.0001
790 SECRETION DISCHARGE 1 0.0001
791 CELLULITIS 4 0.0001
792 ANAEMIA 15 0.0001
793 HYPOPHAGIA 2 0.0001
794 SEIZURE 9 0.0001
795 UNRESPONSIVE TO STIMULI 2 0.0001
796 RESPIRATORY TRACT INFECTION 2 0.0001
797 ORAL CANDIDIASIS 1 0.0001
798 PULMONARY CONGESTION 1 0.0001
799 ABNORMAL BEHAVIOUR 3 0.0001
800 NEUROPATHY PERIPHERAL 7 0.0001
801 RESPIRATORY ARREST 2 0.0001
802 ANAPHYLACTIC REACTION 4 0.0001
803 WEIGHT INCREASED 16 0.0001
804 HYPERTENSION 15 0.0001
805 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
806 LIVER FUNCTION TEST ABNORMAL 2 0.0001
807 PULMONARY MASS 1 0.0001
808 THERAPY NON-RESPONDER 3 0.0001
809 PRODUCT QUALITY ISSUE 9 0.0001
810 THERAPEUTIC RESPONSE DECREASED 4 0.0001
811 EPILEPSY 2 0.0001
812 TOXICITY TO VARIOUS AGENTS 11 0.0001
813 FEMUR FRACTURE 2 0.0001
814 THERAPY PARTIAL RESPONDER 1 0.0001
815 MENINGIOMA 1 0.0001
816 ARRHYTHMIA 3 0.0001
817 PNEUMOTHORAX 1 0.0001
818 HALLUCINATION, AUDITORY 1 0.0001
819 CYSTITIS 2 0.0001
820 DRUG INEFFECTIVE 82 0.0001
821 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
822 HAEMOGLOBIN DECREASED 6 0.0001
823 ORTHOSTATIC HYPOTENSION 1 0.0001
824 COVID-19 10 0.0001
825 METASTASES TO LIVER 1 0.0001
826 DRUG INTERACTION 9 0.0001
827 DRUG ERUPTION 1 0.0001
828 ISCHAEMIC STROKE 1 0.0001
829 CONFUSIONAL STATE 9 0.0001
830 DISTURBANCE IN ATTENTION 3 0.0001
831 PELVIC PAIN 1 0.0001
832 END STAGE RENAL DISEASE 1 0.0001
833 DYSURIA 2 0.0001
834 INFLUENZA 6 0.0001
835 BACTERIAL INFECTION 1 0.0001
836 BLISTER 3 0.0001
837 HALLUCINATION 4 0.0001
838 INTESTINAL OBSTRUCTION 2 0.0001
839 HYPOCALCAEMIA 1 0.0001
840 DIABETES MELLITUS 4 0.0001
841 HAEMORRHOIDS 1 0.0001
842 PLASMA CELL MYELOMA 2 0.0001
843 ORAL HERPES 1 0.0001
844 OVERDOSE 11 0.0001
845 DISABILITY 1 0.0001
846 PRESCRIBED UNDERDOSE 1 0.0001
847 CYTOKINE RELEASE SYNDROME 1 0.0000
848 SOMNOLENCE 10 0.0000
849 STOMATITIS 3 0.0000
850 DYSKINESIA 2 0.0000
851 DIARRHOEA 31 0.0000
852 HALLUCINATION, VISUAL 1 0.0000
853 MYALGIA 8 0.0000
854 LIVER FUNCTION TEST INCREASED 1 0.0000
855 VAGINAL HAEMORRHAGE 2 0.0000
856 ANGIOEDEMA 2 0.0000
857 BLOOD PRESSURE DECREASED 3 0.0000
858 DEHYDRATION 6 0.0000
859 RASH PAPULAR 1 0.0000
860 HEPATIC ENZYME INCREASED 3 0.0000
861 MUSCLE TWITCHING 1 0.0000
862 HYPERSENSITIVITY 8 0.0000
863 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
864 PULMONARY EMBOLISM 4 0.0000
865 PRODUCT PRESCRIBING ERROR 1 0.0000
866 PRODUCT COMPLAINT 1 0.0000
867 FLUID RETENTION 2 0.0000
868 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
869 ABDOMINAL DISTENSION 4 0.0000
870 ECZEMA 2 0.0000
871 PANCREATITIS 2 0.0000
872 EAR INFECTION 1 0.0000
873 FREQUENT BOWEL MOVEMENTS 1 0.0000
874 THROAT TIGHTNESS 1 0.0000
875 RASH PRURITIC 2 0.0000
876 SKIN LESION 1 0.0000
877 TREATMENT FAILURE 3 0.0000
878 MENTAL STATUS CHANGES 1 0.0000
879 PAIN IN JAW 1 0.0000
880 URINARY TRACT INFECTION 6 0.0000
881 RED BLOOD CELL COUNT DECREASED 1 0.0000
882 ANGINA PECTORIS 1 0.0000
883 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
884 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
885 URINARY INCONTINENCE 1 0.0000
886 RENAL INJURY 1 0.0000
887 IRRITABILITY 2 0.0000
888 BLOOD POTASSIUM DECREASED 1 0.0000
889 APHASIA 1 0.0000
890 DRUG ADMINISTRATION ERROR 1 0.0000
891 CARDIAC DISORDER 3 0.0000
892 SWOLLEN TONGUE 1 0.0000
893 DRUG-INDUCED LIVER INJURY 1 0.0000
894 DYSPHAGIA 3 0.0000
895 LACTIC ACIDOSIS 1 0.0000
896 CHOLELITHIASIS 1 0.0000
897 OSTEONECROSIS 1 0.0000
898 EXPIRED PRODUCT ADMINISTERED 1 0.0000
899 LIP SWELLING 1 0.0000
900 VOMITING 14 0.0000
901 NEUTROPENIA 4 0.0000
902 ABDOMINAL PAIN UPPER 6 0.0000
903 HYPERKALAEMIA 1 0.0000
904 SLEEP DISORDER 2 0.0000
905 LYMPHADENOPATHY 1 0.0000
906 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
907 MYELOSUPPRESSION 1 0.0000
908 DRUG EFFECT INCOMPLETE 1 0.0000
909 CRYING 1 0.0000
910 ACCIDENTAL OVERDOSE 1 0.0000
911 DYSGEUSIA 2 0.0000
912 EYE SWELLING 1 0.0000
913 DYSARTHRIA 1 0.0000
914 INCORRECT DOSE ADMINISTERED 6 0.0000
915 HOSPITALISATION 4 0.0000
916 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
917 RASH 11 0.0000
918 THROMBOSIS 2 0.0000
919 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
920 OEDEMA PERIPHERAL 3 0.0000
921 NEUTROPHIL COUNT DECREASED 1 0.0000
922 OSTEOPOROSIS 1 0.0000
923 POLLAKIURIA 1 0.0000
924 COLITIS ULCERATIVE 1 0.0000
925 GASTROINTESTINAL DISORDER 2 0.0000
926 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
927 SKIN DISCOLOURATION 1 0.0000
928 ADVERSE EVENT 2 0.0000
929 COGNITIVE DISORDER 1 0.0000
930 ANXIETY 6 0.0000
931 CONTUSION 2 0.0000
932 HYPOGLYCAEMIA 1 0.0000
933 SINUSITIS 2 0.0000
934 THERAPY CESSATION 1 0.0000
935 DERMATITIS ATOPIC 1 0.0000
936 ASTHENIA 7 0.0000
937 MEDICATION ERROR 1 0.0000
938 BONE PAIN 1 0.0000
939 CHILLS 2 0.0000
940 SURGERY 1 0.0000
941 SUICIDE ATTEMPT 1 0.0000
942 PRODUCT USE ISSUE 3 0.0000
943 INTENTIONAL OVERDOSE 1 0.0000
944 DEEP VEIN THROMBOSIS 1 0.0000
945 SWELLING FACE 1 0.0000
946 INSOMNIA 4 0.0000
947 WEIGHT DECREASED 4 0.0000
948 THERAPY INTERRUPTED 1 0.0000
949 AGITATION 1 0.0000
950 BRONCHITIS 1 0.0000
951 UNEVALUABLE EVENT 1 0.0000
952 CHRONIC KIDNEY DISEASE 1 0.0000
953 DECREASED APPETITE 3 0.0000
954 INJECTION SITE HAEMORRHAGE 1 0.0000
955 CARDIAC FAILURE CONGESTIVE 1 0.0000
956 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
957 DRY MOUTH 1 0.0000
958 INFLUENZA LIKE ILLNESS 1 0.0000
959 TREMOR 2 0.0000
960 URTICARIA 2 0.0000
961 SKIN EXFOLIATION 1 0.0000
962 CEREBROVASCULAR ACCIDENT 2 0.0000
963 PRODUCT STORAGE ERROR 1 0.0000
964 ADVERSE DRUG REACTION 1 0.0000
965 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
966 OROPHARYNGEAL PAIN 1 0.0000
967 BREAST CANCER 1 0.0000
968 COUGH 3 0.0000
969 SWELLING 1 0.0000
970 DYSPNOEA 6 0.0000
971 HEART RATE INCREASED 1 0.0000
972 FLUSHING 1 0.0000
973 PAIN 6 0.0000
974 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
975 FALL 3 0.0000
976 DEPRESSION 2 0.0000
977 HEADACHE 5 0.0000
978 LOSS OF CONSCIOUSNESS 1 0.0000
979 ARTHRALGIA 3 0.0000
980 PAIN IN EXTREMITY 2 0.0000
981 HYPOAESTHESIA 1 0.0000
982 BLOOD PRESSURE INCREASED 1 0.0000
983 MYOCARDIAL INFARCTION 1 0.0000
984 ERYTHEMA 1 0.0000
985 BACK PAIN 1 0.0000
986 FEELING ABNORMAL 1 0.0000
987 NAUSEA 3 0.0000
988 INJECTION SITE PAIN 1 0.0000
989 MALAISE 1 0.0000
990 DIZZINESS 1 0.0000
991 FATIGUE 1 0.0000